\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ masses\\,\\ discharge\\ or\\ skin\\ changes\\ by\\ physical\\ examination\\.\ \(0\)\
\-\ upfront\\ chemotherapy\\ followed\\ by\\ radiation\\ therapy\\ after\\ delivery\\ of\\ the\\ baby\\.\\ patient\\ considering\\ modified\\ radical\\ mastectomy\\ with\\ chemotherapy\\ and\\ hormonal\\ therapy\\ after\\ delivery\\ of\\ the\\ baby\\.\ \(0\)\
\-\ mammogram\\ \\‚\\Ä\\ì\\ 2\\ cm\\ of\\ architectural\\ distortion\\ present\\ in\\ the\\ right\\ upper\\ outer\\ quadrant\\.\\ us\\ was\\ negative\\.\ \(0\)\
\-\ infiltrating\\ ductal\\ carcinoma\ \(11\)\
\-\ malignancy\ \(256\)\
\-\ fibrocystic\\ changes\ \(2\)\
\-\ superimposition\ \(4\)\
\-\ surgical\\ scar\ \(10\)\
\-\ radial\\ sc\ \(3\)\
\-\ 39\\-year\\-old\\ female\\ presents\\ to\\ the\\ reproductive\\ endocrinology\\ clinic\\ for\\ ivf\\.\\ \\ a\\ screening\\ mammogram\\ is\\ performed\\,\\ but\\ not\\ interpreted\\ until\\ after\\ successful\\ ivf\\ is\\ performed\\.\\ \\ pt\\ now\\ at\\ 16\\ weeks\\ pregnancy\\.\ \(0\)\
\-\ breast\\ mass\\ descriptions\\ include\\ location\\,\\ size\\,\\ shape\\,\\ calcifications\\,\\ margins\\,\\ and\\ attenuation\\.\\ \\ location\\ is\\ typically\\ divided\\ into\\ quadrants\\.\\ \\ shape\\ descriptors\\ include\\ round\\,\\ oval\\,\\ lobulated\\,\\ irregular\\,\\ and\\ architectural\\ distortion\\.\\ \\ architectural\\ distortion\\ is\\ a\\ change\\ in\\ the\\ normal\\ breast\\ tissue\\ pattern\\.\\ \\ normal\\ anatomy\\ of\\ the\\ breast\\ involves\\ ducts\\ converging\\ at\\ the\\ nipple\\.\\ \\ distortion\\ is\\ seen\\ as\\ a\\ \\‚\\Ä\\úpulled\\ inward\\‚\\Ä\\ù\\ appearance\\ of\\ this\\ normal\\ architecture\\ in\\ one\\ focal\\ spot\\.\\ \\ \\ breast\\ cancer\\ is\\ the\\ most\\ common\\ cancer\\ in\\ pregnant\\ women\\.\\ \\ termination\\ of\\ pregnancy\\ has\\ not\\ been\\ shown\\ to\\ improve\\ maternal\\ outcomes\\,\\ but\\ is\\ an\\ option\\ in\\ patients\\ with\\ advanced\\ cancers\\ requiring\\ chemo\\ or\\ xrt\\.\\‚\\Ä\\¢rx\\ \\ stage\\ i\\ or\\ ii\\‚\\Ä\\ì\\ modified\\ radical\\ mastectomy\\ \\(as\\ opposed\\ to\\ lumpectomy\\ with\\ radiation\\,\\ which\\ is\\ considered\\ an\\ equivalent\\ rx\\)\\ to\\ avoid\\ radiation\\ exposure\\ to\\ the\\ fetus\\.\\ \\ if\\ adjuvant\\ chemo\\ necessary\\,\\ give\\ after\\ 1st\\ trimester\\.\\‚\\Ä\\¢rx\\ stage\\ iii\\ or\\ iv\\ \\‚\\Ä\\ì\\ surgery\\ with\\ chemo\\ after\\ 1st\\ trimester\\.\\ \\ \\‚\\Ä\\¢5\\ year\\ survival\\ for\\ these\\ patients\\ is\\ 10\\%\\ and\\ fetal\\ risk\\ is\\ incurred\\ during\\ 1st\\ trimester\\ rx\\,\\ therefore\\ therapeutic\\ abortion\\ should\\ be\\ considered\\,\\ although\\ it\\ will\\ not\\ improve\\ outcome\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ distortion\\:\\ 0\\.06659473843518858\ \(0\)\
\-\ chemo\\:\\ 0\\.06226831253290326\ \(0\)\
\-\ architectural\\:\\ 0\\.05586909057085917\ \(0\)\
\-\ 1st\\:\\ 0\\.04948847990211381\ \(0\)\
\-\ ivf\\:\\ 0\\.04151220835526884\ \(0\)\
\-\ rx\\:\\ 0\\.04151220835526884\ \(0\)\
\-\ breast\\:\\ 0\\.041345022214171176\ \(0\)\
\-\ modified\\:\\ 0\\.03753754734825038\ \(0\)\
\-\ trimester\\:\\ 0\\.036442110727508296\ \(0\)\
\-\ radical\\:\\ 0\\.03508054112240506\ \(0\)\
\-\ mastectomy\\:\\ 0\\.03329736921759429\ \(0\)\
\-\ improve\\:\\ 0\\.029854678996230708\ \(0\)\
\-\ mammogram\\:\\ 0\\.02923809571984857\ \(0\)\
\-\ shape\\:\\ 0\\.029154561124586732\ \(0\)\
\-\ after\\:\\ 0\\.028983626272282008\ \(0\)\
\-\ upfront\\:\\ 0\\.028903339094972124\ \(0\)\
\-\ descriptors\\:\\ 0\\.028903339094972124\ \(0\)\
\-\ xrt\\.\\‚\\Ä\\¢rx\\:\\ 0\\.028903339094972124\ \(0\)\
\-\ ii\\‚\\Ä\\ì\\:\\ 0\\.028903339094972124\ \(0\)\
\-\ trimester\\.\\‚\\Ä\\¢rx\\:\\ 0\\.028903339094972124\ \(0\)\
\-\ delivery\\:\\ 0\\.028752141804086452\ \(0\)\
\-\ radiation\\:\\ 0\\.027582799176022983\ \(0\)\
\-\ baby\\:\\ 0\\.027288905402026067\ \(0\)\
\-\ \\‚\\Ä\\¢5\\:\\ 0\\.026630725388218205\ \(0\)\
\-\ incurred\\:\\ 0\\.026630725388218205\ \(0\)\
\-\ converging\\:\\ 0\\.025301331591142256\ \(0\)\
\-\ \\‚\\Ä\\ì\\:\\ 0\\.025217738520593426\ \(0\)\
\-\ descriptions\\:\\ 0\\.024358111681464286\ \(0\)\
\-\ pregnancy\\:\\ 0\\.024090851589926805\ \(0\)\
\-\ stage\\:\\ 0\\.023901865107726863\ \(0\)\
\-\ superimposition\\:\\ 0\\.02362649348043409\ \(0\)\
\-\ 39\\-year\\-old\\:\\ 0\\.02362649348043409\ \(0\)\
\-\ inward\\:\\ 0\\.02362649348043409\ \(0\)\
\-\ considered\\:\\ 0\\.022619950222587847\ \(0\)\
\-\ pulled\\:\\ 0\\.022523305819380935\ \(0\)\
\-\ reproductive\\:\\ 0\\.022085497974710367\ \(0\)\
\-\ termination\\:\\ 0\\.022085497974710367\ \(0\)\
\-\ sc\\:\\ 0\\.02169932408731239\ \(0\)\
\-\ fibrocystic\\:\\ 0\\.02075610417763442\ \(0\)\
\-\ equivalent\\:\\ 0\\.020250692112627016\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02008489039436633\ \(0\)\
\-\ hormonal\\:\\ 0\\.020024485976604223\ \(0\)\
\-\ endocrinology\\:\\ 0\\.020024485976604223\ \(0\)\
\-\ abortion\\:\\ 0\\.020024485976604223\ \(0\)\
\-\ location\\:\\ 0\\.01954562417641897\ \(0\)\
\-\ architecture\\:\\ 0\\.01924944080262314\ \(0\)\
\-\ outcomes\\:\\ 0\\.01924944080262314\ \(0\)\
\-\ give\\:\\ 0\\.019081266066926252\ \(0\)\
\-\ quadrants\\:\\ 0\\.018921298315551064\ \(0\)\
\-\ adjuvant\\:\\ 0\\.01876877367412519\ \(0\)\
\-\ lumpectomy\\:\\ 0\\.0184834904708805\ \(0\)\
\-\ is\\:\\ 0\\.01843576322572871\ \(0\)\
\-\ cancer\\:\\ 0\\.0184207558319001\ \(0\)\
\-\ opposed\\:\\ 0\\.01809731658348252\ \(0\)\
\-\ interpreted\\:\\ 0\\.01764436465403722\ \(0\)\
\-\ divided\\:\\ 0\\.01764436465403722\ \(0\)\
\-\ maternal\\:\\ 0\\.01764436465403722\ \(0\)\
\-\ considering\\:\\ 0\\.01706426397154844\ \(0\)\
\-\ oval\\:\\ 0\\.016976827095869222\ \(0\)\
\-\ cancers\\:\\ 0\\.016891661566678203\ \(0\)\
\-\ outcome\\:\\ 0\\.016727692974630132\ \(0\)\
\-\ nipple\\:\\ 0\\.016648684608797145\ \(0\)\
\-\ pregnant\\:\\ 0\\.01649615996737127\ \(0\)\
\-\ fetus\\:\\ 0\\.01635041648353247\ \(0\)\
\-\ avoid\\:\\ 0\\.016210876764126584\ \(0\)\
\-\ ducts\\:\\ 0\\.016077034159142137\ \(0\)\
\-\ changes\\:\\ 0\\.016059330991705315\ \(0\)\
\-\ therapeutic\\:\\ 0\\.015764541766341074\ \(0\)\
\-\ include\\:\\ 0\\.015719039265772373\ \(0\)\
\-\ option\\:\\ 0\\.015647433298793274\ \(0\)\
\-\ performed\\:\\ 0\\.015623464467064387\ \(0\)\
\-\ requiring\\:\\ 0\\.015479258563096386\ \(0\)\
\-\ infiltrating\\:\\ 0\\.015216823455970035\ \(0\)\
\-\ spot\\:\\ 0\\.015068887602591447\ \(0\)\
\-\ survival\\:\\ 0\\.01502102268645652\ \(0\)\
\-\ therapy\\:\\ 0\\.014981251122889266\ \(0\)\
\-\ successful\\:\\ 0\\.014927339498115354\ \(0\)\
\-\ outer\\:\\ 0\\.014881482967050632\ \(0\)\
\-\ scar\\:\\ 0\\.014619047859924284\ \(0\)\
\-\ exposure\\:\\ 0\\.014577280562293366\ \(0\)\
\-\ patients\\:\\ 0\\.014502128520432957\ \(0\)\
\-\ anatomy\\:\\ 0\\.014495309079652654\ \(0\)\
\-\ advanced\\:\\ 0\\.014337269401561251\ \(0\)\
\-\ fetal\\:\\ 0\\.014261017394465295\ \(0\)\
\-\ \\,\\:\\ 0\\.014201183764841306\ \(0\)\
\-\ lobulated\\:\\ 0\\.01407780277677855\ \(0\)\
\-\ women\\:\\ 0\\.013613374851981743\ \(0\)\
\-\ discharge\\:\\ 0\\.013582588818047841\ \(0\)\
\-\ therefore\\:\\ 0\\.013234081740508094\ \(0\)\
\-\ ductal\\:\\ 0\\.013206644856342467\ \(0\)\
\-\ normal\\:\\ 0\\.013176515946876405\ \(0\)\
\-\ iii\\:\\ 0\\.013152450423715547\ \(0\)\
\-\ or\\:\\ 0\\.013134724576573213\ \(0\)\
\-\ involves\\:\\ 0\\.013020758483632482\ \(0\)\
\-\ radial\\:\\ 0\\.012844847947592088\ \(0\)\
\-\ margins\\:\\ 0\\.012724736035527234\ \(0\)\
\-\ 16\\:\\ 0\\.012677896831437148\ \(0\)\
\-\ clinic\\:\\ 0\\.0125190365580406\ \(0\)\
\-\ necessary\\:\\ 0\\.01241010000843955\ \(0\)\
\-\ until\\:\\ 0\\.012304666855539447\ \(0\)\
\-\ not\\:\\ 0\\.012145757426969857\ \(0\)\
\-\ round\\:\\ 0\\.012103457195289309\ \(0\)\
\-\ screening\\:\\ 0\\.011950932553863432\ \(0\)\
\-\ but\\:\\ 0\\.011950841318252706\ \(0\)\
\-\ us\\:\\ 0\\.011752163302006267\ \(0\)\
\-\ i\\:\\ 0\\.011581359656486918\ \(0\)\
\-\ attenuation\\:\\ 0\\.011264331378446029\ \(0\)\
\-\ shown\\:\\ 0\\.0112342514562295\ \(0\)\
\-\ irregular\\:\\ 0\\.011174907057397966\ \(0\)\
\-\ change\\:\\ 0\\.010920398329428994\ \(0\)\
\-\ malignancy\\:\\ 0\\.010826523533775462\ \(0\)\
\-\ skin\\:\\ 0\\.01076107847619337\ \(0\)\
\-\ pattern\\:\\ 0\\.010709647013348454\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.010463937435341507\ \(0\)\
\-\ pt\\:\\ 0\\.010416930343058205\ \(0\)\
\-\ calcifications\\:\\ 0\\.010416930343058205\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.010405283124683229\ \(0\)\
\-\ iv\\:\\ 0\\.010224344057249488\ \(0\)\
\-\ risk\\:\\ 0\\.010148218515931432\ \(0\)\
\-\ typically\\:\\ 0\\.009889920555757286\ \(0\)\
\-\ quadrant\\:\\ 0\\.009860248963888704\ \(0\)\
\-\ now\\:\\ 0\\.00957742816295622\ \(0\)\
\-\ masses\\:\\ 0\\.009470794747528155\ \(0\)\
\-\ although\\:\\ 0\\.009462063215005258\ \(0\)\
\-\ 10\\:\\ 0\\.009444669601137412\ \(0\)\
\-\ followed\\:\\ 0\\.009393035643864824\ \(0\)\
\-\ size\\:\\ 0\\.009393035643864824\ \(0\)\
\-\ by\\:\\ 0\\.009330301004884425\ \(0\)\
\-\ should\\:\\ 0\\.00893183128488131\ \(0\)\
\-\ will\\:\\ 0\\.008765511535669318\ \(0\)\
\-\ examination\\:\\ 0\\.008709583722867427\ \(0\)\
\-\ during\\:\\ 0\\.008573800819422321\ \(0\)\
\-\ as\\:\\ 0\\.008475918071436904\ \(0\)\
\-\ negative\\:\\ 0\\.008367607086474998\ \(0\)\
\-\ appearance\\:\\ 0\\.0080128084483103\ \(0\)\
\-\ focal\\:\\ 0\\.008001618374224268\ \(0\)\
\-\ weeks\\:\\ 0\\.007951730350495569\ \(0\)\
\-\ carcinoma\\:\\ 0\\.007940746459068415\ \(0\)\
\-\ an\\:\\ 0\\.007748622060883475\ \(0\)\
\-\ been\\:\\ 0\\.007622278326111447\ \(0\)\
\-\ if\\:\\ 0\\.007602437487805362\ \(0\)\
\-\ one\\:\\ 0\\.007592561912493915\ \(0\)\
\-\ at\\:\\ 0\\.007591889526764806\ \(0\)\
\-\ cm\\:\\ 0\\.007514610222350773\ \(0\)\
\-\ common\\:\\ 0\\.007332023645758679\ \(0\)\
\-\ these\\:\\ 0\\.007291294071992918\ \(0\)\
\-\ to\\:\\ 0\\.007001116531852234\ \(0\)\
\-\ in\\:\\ 0\\.006908151313774672\ \(0\)\
\-\ physical\\:\\ 0\\.006873787769118814\ \(0\)\
\-\ surgery\\:\\ 0\\.00680327562085336\ \(0\)\
\-\ upper\\:\\ 0\\.006760919689733503\ \(0\)\
\-\ into\\:\\ 0\\.0066666438293760885\ \(0\)\
\-\ tissue\\:\\ 0\\.006640725208041291\ \(0\)\
\-\ \\%\\:\\ 0\\.006535478797855762\ \(0\)\
\-\ most\\:\\ 0\\.006468311940092053\ \(0\)\
\-\ present\\:\\ 0\\.006327897553874363\ \(0\)\
\-\ it\\:\\ 0\\.006297863555845956\ \(0\)\
\-\ 2\\:\\ 0\\.006033129496755889\ \(0\)\
\-\ surgical\\:\\ 0\\.00588925170574247\ \(0\)\
\-\ female\\:\\ 0\\.005759869742451913\ \(0\)\
\-\ presents\\:\\ 0\\.005723423919698118\ \(0\)\
\-\ seen\\:\\ 0\\.005536483983828493\ \(0\)\
\-\ has\\:\\ 0\\.005261311378669763\ \(0\)\
\-\ which\\:\\ 0\\.005229982253254258\ \(0\)\
\-\ for\\:\\ 0\\.004781037040280099\ \(0\)\
\-\ be\\:\\ 0\\.0043205138470292755\ \(0\)\
\-\ the\\:\\ 0\\.004079487089615187\ \(0\)\
\-\ a\\:\\ 0\\.003900981657232144\ \(0\)\
\-\ mass\\:\\ 0\\.003896593465401851\ \(0\)\
\-\ was\\:\\ 0\\.003240254171192416\ \(0\)\
\-\ this\\:\\ 0\\.0031512695518496167\ \(0\)\
\-\ year\\:\\ 0\\.003134771374665294\ \(0\)\
\-\ right\\:\\ 0\\.0029561695380669398\ \(0\)\
\-\ no\\:\\ 0\\.0028211283629632853\ \(0\)\
\-\ patient\\:\\ 0\\.0028084981341520918\ \(0\)\
\-\ \\(\\:\\ 0\\.002368399102438887\ \(0\)\
\-\ and\\:\\ 0\\.0023607738456684385\ \(0\)\
\-\ \\)\\:\\ 0\\.002339467842994443\ \(0\)\
\-\ of\\:\\ 0\\.0022918780484850183\ \(0\)\
\-\ \\.\\:\\ 0\\.0020950545893515834\ \(0\)\
\-\ with\\:\\ 0\\.0015344809979001932\ \(0\)\
